Klyss Biotech, Inc Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

Klyss Biotech, Inc. is a biotechnology research company based in Santa Monica, California. The firm focuses on developing monoclonal antibodies for potential therapies targeting hematological malignancies, including multiple myeloma and certain non-Hodgkin lymphomas. Its lead candidate, ch128.1, binds the transferrin receptor (CD71), a surface molecule expressed at high levels on cancer cells, with non-neutralizing properties that may allow tumor targeting while minimizing interference from natural TfR ligands. Early studies in mouse models have demonstrated tumor protection and, in some cases, long-term survival, suggesting potential applicability across aggressive hematologic cancers. The company operates with a small team and is positioned within the biotechnology research sector, pursuing therapies that address difficult-to-treat blood cancers.

Sign up for free to view info

Company overview Employee directory